News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Gilead Sciences, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Policy
Gilead, Sanofi Scored Lowest in Disclosing Clinical Trial Data While GlaxoSmithKline, Johnson & Johnson and Pfizer Ranked Highest
November 12, 2015
·
3 min read
Biotech Bay
Gilead’s Blockbuster Sovaldi Linked to Slower Heartbeats and Puts Patients at Risk of Passing Out
November 5, 2015
·
3 min read
Policy
AbbVie’s Pain is Gilead’s Gain After FDA Slaps Warning on AbbVie’s Hepatitis Drugs
October 23, 2015
·
3 min read
Drug Development
Johnson & Johnson Battles Gilead for a Chunk of the Hepatitis C Market, Tries to Cut Treatment Time in Half
October 20, 2015
·
3 min read
Deals
Why Gilead and Roche Should Take a Good Look at Clovis Oncology as Possible M&A Target
October 6, 2015
·
3 min read
Drug Development
Gilead Beats AbbVie Again
September 22, 2015
·
1 min read
Biotech Bay
Why Gilead Is A Buy (Hint: It’s Not Hepatitis C)
September 21, 2015
·
1 min read
Biotech Bay
Encouraging Results From Real-World Users Of Gilead’s HIV-Prevention Pill Truvada
September 14, 2015
·
1 min read
Deals
Gilead Borrows $10 Billion, Spurring Acquisition Speculation
September 10, 2015
·
3 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Drug Development
Gilead Announces Results From Studies Evaluating Sofosbuvir-Based Regimens In Chronic Hepatitis C Patients With Genotypes 2-5
April 27, 2015
·
9 min read
Business
Gilead To Release First Quarter 2015 Financial Results On Thursday, April 30, 2015
April 24, 2015
·
1 min read
Drug Development
Gilead’s Hepatitis C Combo Shows Cure Rate of 93% At Six Weeks, Fails at Four
April 23, 2015
·
4 min read
Drug Development
Gilead’s Harvoni And Sovaldi Demonstrate Efficacy And Safety Among Chronic Hepatitis C Patients With Advanced Liver Disease
April 23, 2015
·
10 min read
Policy
Gilead Submits New Drug Application To U.S.FDA For Fixed-Dose Combination Of Emtricitabine/Tenofovir Alafenamide For HIV Treatment
April 8, 2015
·
4 min read
Biotech Beach
BioSpace Temperature Poll: After Injuries and Death, What Penalty Will Gilead Pay?
April 2, 2015
·
1 min read
FDA
Japan’s Ministry Of Health, Labour And Welfare Approves Gilead’s Sovaldi (Sofosbuvir) For The Treatment Of Genotype 2 Chronic Hepatitis C
March 26, 2015
·
5 min read
Business
Gilead’s $600 Million Man
March 25, 2015
·
1 min read
Gilead Release: Multiple Provinces Align To Provide Public Funding For Harvoni, The First Single Tablet Regimen For The Treatment Of Genotype 1 Chronic Hepatitis C Virus Infection
March 24, 2015
·
1 min read
FDA
Hetero Received Generic Sofosbuvir (Gilead’s Sovaldi) Approval From Drug Controller General Of India (DCGI)
March 12, 2015
·
1 min read
